AppLovin's Falling Knife, Adtech Thesis Explored - Contrarian Buy (NASDAQ:APP)
· seekingalpha.com
APP faces walled-garden ad pressure but strong FQ2’26 results and FQ3 guidance support a deep value buy at 14.95x EV/EBITDA—read the thesis now.
I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view ...